Indeterminate human immunodeficiency virus type western blots seroconversion risk specificity supplemental tests algorithm evaluation human immunodeficiency virus type Western blot indeterminate sera reactive EIA Eighty-nine individuals prior reactive EIA Western blots risk seroconversion specificity supplemental tests high-risk cases months enrollment seroconversion risk confidence interval cases bands high-risk individuals low-risk cases Specificities culture serum antigen polymerase chain reaction recombinant ENV EIA expedited evaluation protocol Low-risk individuals nonreactive EIAs repeat follow-up high-risk individuals months bands Western blot 